SI
BDSX icon

Stephens Inc’s Biodesix BDSX Stock Holding History

Stephens Inc’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,896
Closed -$55.9K – 1326
2025
Q2 		$55.9K Hold
9,896
– – ﹤0.01% 1245
2025
Q1 		$124K Hold
9,896
– – ﹤0.01% 1165
2024
Q4 		$303K Buy
+9,896
New +$291K ﹤0.01% 1009

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stephens Inc's BDSX Position: Q3 2025 in Review

Stephens Inc sold out of Biodesix (BDSX) in Q3 2025, closing a stake of 9,896 shares — an estimated $55.9K sold.

Stephens Inc first reported a position in BDSX in Q4 2024 and held it in 3 quarters. The position peaked at $303K in Q4 2024. 26 funds tracked by Wall St. Rank hold BDSX as of Q3 2025.

  • Stephens Inc reported no remaining Biodesix position as of Q3 2025 after selling out during the quarter.
  • Stephens Inc sold 9,896 Biodesix shares in Q3 2025, an estimated $55.9K.
  • Stephens Inc first reported a position in Biodesix in Q4 2024 and held it in 3 quarters.
  • Stephens Inc's Biodesix position peaked at $303K in Q4 2024.
  • 26 funds tracked by Wall St. Rank held Biodesix as of Q3 2025.

Based on Stephens Inc's 13F filing for Q3 2025, filed 27 Oct 2025.